# EDGAR Filing Document

**Accession Number:** 0000014693
**File Stem:** 0001193125-26-255001
**Filing Date:** 2026-6
**Character Count:** 17596
**Document Hash:** 85b6116804466ad8552446b408b971af
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-255001.hdr.sgml**: 20260603

**ACCESSION NUMBER**: 0001193125-26-255001

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D/A

**PUBLIC DOCUMENT COUNT**: 8

**FILED AS OF DATE**: 20260603

**DATE AS OF CHANGE**: 20260603

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BROWN FORMAN CORP
- **CENTRAL INDEX KEY:** 0000014693
- **STANDARD INDUSTRIAL CLASSIFICATION:** BEVERAGES [2080]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 610143150
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0430

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-14029
- **FILM NUMBER:** 261059740

**BUSINESS ADDRESS:**
- **STREET 1:** 850 DIXIE HWY
- **CITY:** LOUISVILLE
- **STATE:** KY
- **ZIP:** 40210
- **BUSINESS PHONE:** 5025851100

**MAIL ADDRESS:**
- **STREET 1:** 850 DIXIE HIGHWAY
- **CITY:** LOUISVILLE
- **STATE:** KY
- **ZIP:** 40210

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** BROWN FORMAN INC
- **DATE OF NAME CHANGE:** 19870816

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** BROWN FORMAN DISTILLERS CORP
- **DATE OF NAME CHANGE:** 19840807

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** BROWN FORMAN DISTILLERY CO
- **DATE OF NAME CHANGE:** 19670730
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Wolf Pen Branch, LP
- **CENTRAL INDEX KEY:** 0001701991

**ORGANIZATION NAME:**
- **EIN:** 820863533
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A

**BUSINESS ADDRESS:**
- **STREET 1:** 4969 U.S. HIGHWAY 42
- **STREET 2:** SUITE 2000
- **CITY:** LOUISVILLE
- **STATE:** KY
- **ZIP:** 40222
- **BUSINESS PHONE:** 502-212-7800

**MAIL ADDRESS:**
- **STREET 1:** 4969 U.S. HIGHWAY 42
- **STREET 2:** SUITE 2000
- **CITY:** LOUISVILLE
- **STATE:** KY
- **ZIP:** 40222

### Attached PDF Documents

**Attachment 1:** `ck0000000000-ex99_a.pdf`

_No text found in this document._

**Attachment 2:** `ck0000000000-ex99_b.pdf`

_No text found in this document._

**Attachment 3:** `ck0000000000-ex99_c.pdf`

_No text found in this document._

**Attachment 4:** `ck0000000000-ex99_d.pdf`

_No text found in this document._

**Attachment 5:** `ck0000000000-ex99_e.pdf`

_No text found in this document._

**Attachment 6:** `ck0000000000-ex99_1.pdf`

_No text found in this document._

**Attachment 7:** `ck0000000000-ex99_2.pdf`

_No text found in this document._

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**(Amendment No. 2)**

**Brown-Forman Corporation**

*(Name of Issuer)*

**Class A Common Stock (voting), $0.15 par value per share**

*(Title of Class of Securities)*

**—**

*(CUSIP Number)*

**Wolf Pen Branch, LP**<br>c/o The Glenview Trust Company<br>5900 U.S. Highway 42<br>Louisville KY 40241<br>(502) 212-7800

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**06/03/2026**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **—** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Wolf Pen Branch, LP** | Name of reporting person<br>**Wolf Pen Branch, LP** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**101601480.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**42000000.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**101601480.00** | Aggregate amount beneficially owned by each reporting person<br>**101601480.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**60.3%** | Percent of class represented by amount in Row (11)<br>**60.3%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**PN** | Type of Reporting Person (See Instructions)<br>**PN** | |

---

**Comment for Reporting Person:** Row 4: See Item 3 of Original Schedule 13D (as defined under Item 1 below).
Row 13: Based upon 168,441,239 shares of Class A Common Stock (voting) outstanding as of February 28, 2026 as disclosed in Brown-Forman Corporation's Quarterly Report on Form 10-Q for the quarter ended January 31, 2026, filed with the Securities and Exchange Commission on March 4, 2026.

| **CUSIP No.** | **—** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Wolf Pen Branch GP, LLC** | Name of reporting person<br>**Wolf Pen Branch GP, LLC** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**101601480.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**42000000.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**101601480.00** | Aggregate amount beneficially owned by each reporting person<br>**101601480.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**60.3%** | Percent of class represented by amount in Row (11)<br>**60.3%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**OO** | Type of Reporting Person (See Instructions)<br>**OO** | |

---

**Comment for Reporting Person:** Row 4: See Item 3 of Original Schedule 13D.
Row 7: Wolf Pen Branch GP, LLC has voting power with respect to these shares (which are the same shares in respect of which Wolf Pen Branch, LP has voting power) by virtue of serving as general partner of Wolf Pen Branch, LP. Wolf Pen Branch GP, LLC does not directly hold any of these shares.
Row 9: Wolf Pen Branch GP, LLC has dispositive power with respect to these shares (which are the same shares in respect of which Wolf Pen Branch, LP has dispositive power) by virtue of serving as general partner of Wolf Pen Branch, LP. Wolf Pen Branch GP, LLC does not directly hold any of these shares.
Row 13: Based upon 168,441,239 shares of Class A Common Stock (voting) outstanding as of February 28, 2026 as disclosed in Brown-Forman Corporation's Quarterly Report on Form 10-Q for the quarter ended January 31, 2026, filed with the Securities and Exchange Commission on March 4, 2026.

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Class A Common Stock (voting), $0.15 par value per share

**(b) Name of Issuer:**
Brown-Forman Corporation

**(c) Address of Issuer's Principal Executive Offices:**
850 DIXIE HWY, LOUISVILLE, KY, 40210

This Amendment No. 2 to Schedule 13D ("Amendment No. 2") amends the Schedule 13D filed on March 28, 2017 (the "Original Schedule 13D"), as amended by Amendment No. 1 to the Original Schedule 13D filed on March 29, 2019 ("Amendment No. 1" and, collectively, with the Original Schedule 13D, the "Prior Schedule 13D"), by Wolf Pen Branch, LP, a Delaware limited partnership ("HoldCo"), and Wolf Pen Branch GP, LLC, a Delaware limited liability company ("General Partner"), which serves as the sole general partner of HoldCo (HoldCo and General Partner, collectively, the "Reporting Persons"), relating to Class A Common Stock (voting), $0.15 par value per share ("Common Stock"), issued by Brown-Forman Corporation (the "Registrant"). This Amendment No. 2 is being filed as a result of certain developments that have occurred since the filing of Amendment No. 1, including as a result of the receipt by HoldCo of additional Proxies (as defined in Item 6 below) since the filing of Amendment No. 1,  which has caused the beneficial ownership of the shares of Common Stock held by HoldCo and the General Partner to increase, as more specifically set forth in Items 5 and 6 below. Except for the amended items set forth in this Amendment No. 2, the Prior Schedule 13D is unmodified and remains in full force and effect. Each capitalized term used but not defined herein has the meaning ascribed to such term in the Original Schedule 13D.

**Item 5. Interest in Securities of the Issuer**

**(a)**
Item 5 of the Schedule 13D is hereby amended and restated as follows:

As of the date hereof, each of the Reporting Persons is the beneficial owner of 101,601,480 shares of Common Stock, which represents 60.3% of the outstanding shares of Common Stock. Of these shares in respect of which the Reporting Persons have beneficial ownership, HoldCo has sole voting power and sole dispositive power with respect to 42,000,000 shares of Common Stock (which includes 42,000,000 of the Contributed Shares), and the General Partner also has sole voting power and sole dispositive power with respect to the Contributed Shares by virtue of serving as the general partner of HoldCo.

In addition, HoldCo has sole voting power with respect to 59,601,480 shares of Common Stock (the "Proxy Shares") in respect of which HoldCo has received irrevocable proxies pursuant to Proxies, all as further described in Item 6 below, and the General Partner also has sole voting power with respect to the Proxy Shares by virtue of serving as the general partner of HoldCo. As described in Item 6 below, since the filing of Amendment No. 1, HoldCo has received irrevocable proxies pursuant to Proxies for an additional 7,095,855 Proxy Shares, in addition to the 52,505,625 Proxy Shares in respect of which HoldCo had received irrevocable proxies pursuant to Proxies at the time of the filing of Amendment No. 1 as disclosed therein.

As of the date hereof, the Covered Individuals beneficially own the number and percentage of shares of Common Stock set forth in Schedule B, which is incorporated herein by reference.

**(b)**
See Item 5(a) above for information regarding the shares of Common Stock beneficially owned by the Reporting Persons in respect of which the Reporting Persons have sole voting power and sole dispositive power. The Reporting Persons do not have shared voting power or shared dispositive power with respect to any shares of Common Stock.

To the Reporting Persons' knowledge, none of the Covered Individuals has shared voting power or shared dispositive power with respect to any shares of Common Stock.

**(c)**
One of the Covered Individuals engaged in a transaction during the 60-day period prior to the filing of this Schedule 13D as set forth on Schedule C attached hereto.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

Background

      At the time of the filing of the Original Schedule 13D, as disclosed therein, each limited partner entity of HoldCo (the "Limited Partner Entities") other than Alcyone Spirits, LLC ("Alcyone") provided irrevocable proxies to HoldCo pursuant to Irrevocable Proxy Substitution and Agreements in substantially the form attached as Exhibit 4 to the Original Schedule 13D (the "Limited Partner / Associated Party Irrevocable Proxies") covering 42,287,463 Proxy Shares (including the Pledged Proxy Shares, as defined below). In addition, as disclosed in the Original Schedule 13D, each of these Limited Partner Entities received irrevocable proxies with respect to these Proxy Shares from Brown Family Participants represented by such Limited Partner Entity in substantially the form attached as Exhibit 5 to the Original Schedule 13D (the "Irrevocable Proxies") (provided, that one of the Limited Partner Entities also received irrevocable proxies with respect to 2,415,000 Proxy Shares (the "Pledged Proxy Shares") pledged by Brown Family Participants represented by such Limited Partner Entity in substantially the form attached as Exhibit 6 to the Original Schedule 13D (the "Pledged Shares Irrevocable Proxies"; the Limited Partner / Associated Party Irrevocable Proxies, the Irrevocable Proxies and the Pledged Shares Irrevocable Proxies, collectively, the "Proxies")). In addition, at the time of the filing of the Original Schedule 13D, as disclosed therein, Alcyone provided an irrevocable proxy directly to HoldCo pursuant to an Irrevocable Proxy covering 4,186,454 Proxy Shares (the "Direct Alcyone Proxy Shares").

      Following the filing of the Original Schedule 13D, and at the time of the filing of Amendment No. 1, five of the Limited Partner Entities (including Alcyone) provided irrevocable proxies to HoldCo on March 28, 2019 pursuant to Limited Partner / Associated Party Irrevocable Proxies covering 5,538,820 Proxy Shares. Each of these Limited Partner Entities received an Irrevocable Proxy with respect to these Proxy Shares from Brown Family Participants represented by such Limited Partner Entity.

      In addition, following the filing of the Original Schedule 13D, and at the time of the filing of Amendment No. 1, the number of the Direct Alcyone Proxy Shares subject to the Irrevocable Proxy previously provided to HoldCo by Alcyone increased by 492,888 Proxy Shares.

      Following the filing of Amendment No. 1 and prior to the filing of this Amendment No. 2, six of the Limited Partner Entities provided irrevocable proxies to HoldCo pursuant to Limited Partner / Associated Party Irrevocable Proxies covering in the aggregate 1,286,061 Proxy Shares. Each of these Limited Partner Entities has received an Irrevocable Proxy with respect to these Proxy Shares from Brown Family Participants represented by such Limited Partner Entity. Additionally, since the filing of Amendment No. 1, as a result of collateral changes or other actions related to the Pledged Proxy Shares, the number of Pledged Proxy Shares held by Brown Family Participants represented by such Limited Partner Entity has been reduced to 1,115,623 Proxy Shares, and the portion of the Pledged Proxy Shares that was previously subject to Pledged Shares Irrevocable Proxies is now subject to Irrevocable Proxies. The entities providing Pledged Shares Irrevocable Proxies to the Limited Partner Entity are set forth on Schedule E.

      In addition, at the time of the filing of this Amendment No. 2, HoldCo has received Limited Partner / Associated Party Irrevocable Proxies from a descendant of Robinson S. Brown, Jr. (the "RSB Proxy Holder") covering in the aggregate 5,809,794 Proxy Shares (such amount includes 122,800 Proxy Shares subject to Pledged Shares Irrevocable Proxies) in connection with an association agreement entered into by and among HoldCo, the General Partner and the RSB Proxy Holder (the "Association Agreement"). The RSB Proxy Holder has received Irrevocable Proxies with respect to these Proxy Shares from certain members of the RSB Proxy Holder's family branch (the "RSB Branch Participants" and, together with the Brown Family Participants, the "Expanded Brown Family Participants").

Additional disclosure related to this Item 6 is set forth on Schedule D, which is incorporated herein by reference.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Wolf Pen Branch, LP

**Signature:** By: Wolf Pen Branch GP, LLC, its general partner, By: /s/ Martin S. Brown, Jr.

**Name/Title:** Martin S. Brown, Jr., Chairman

**Date:** 06/03/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Wolf Pen Branch GP, LLC

**Signature:** By: /s/ Martin S. Brown, Jr.

**Name/Title:** Martin S. Brown, Jr., Chairman

**Date:** 06/03/2026